In fact, a recent positron emission tomography study targeting vesicular monoamine transporter type 2 (VMAT2) binding sites reported that striatal VMAT2 binding was abnormal in a subset of chronic DIP cases and differs in spatial distribution from PD.21 Here, SLC18A2 is linked to Parkinson disease.